Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: An Open-Label, Multicenter, Phase 2 Clinical Trial in China

Blood (2024) 144 (Supplement 1): 6602.

https://doi.org/10.1182/blood-2024-208258

Published: 2024

Journal Articles

Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism

Eriko Nitta, Masayuki Yamashita, Kentaro Hosokawa, MingJi Xian, Keiyo Takubo, Fumio Arai, Shinichiro Nakada, Toshio Suda

Blood (2011) 117 (16): 4169–4180.

https://doi.org/10.1182/blood-2010-08-297390

Published: 2011

Includes: Supplemental data

Journal Articles

A Novel Putative Mechanism of Anti-Myeloma Activity Targeted Against Heat Shock Protein 27 by Derivative of Artemisinin, Artesunate.

Aki Chizuka, Hideo Uchida, MingJi Xian, Takayuki Shimizu, Yasuo Ikeda, Masahiro Kizaki

Blood (2007) 110 (11): 1521.

https://doi.org/10.1182/blood.V110.11.1521.1521

Published: 2007

Journal Articles

Myeloperoxidase (MPO) Is a Key Regulator of Oxidative Stress-Mediated Apoptosis in Myeloid Leukemic Cells.

Masahiro Kizaki, MD, Tomonori Nakazato, MD, Morihiko Sagawa, MD, Kenji Yamato, MD, Mingji Xian, MD, Yasuo Ikeda, MD

Blood (2006) 108 (11): 1923.

https://doi.org/10.1182/blood.V108.11.1923.1923

Published: 2006

Journal Articles

A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.

Morihiko Sagawa, MD, Takatsune Shimizu, MD, Mingji Xian, MD, Aki Chizuka, MD, Naoshi Fukushima, PhD, Yasuko Kinoshita, PhD, Iwao Ohizumi, PhD, Yasuo Ikeda, MD, Hisafumi Okabe, PhD, Masahiro Kizaki, MD

Blood (2006) 108 (11): 2097.

https://doi.org/10.1182/blood.V108.11.2097.2097

Published: 2006

NARROW

Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: An Open-Label, Multicenter, Phase 2 Clinical Trial in China

Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism

A Novel Putative Mechanism of Anti-Myeloma Activity Targeted Against Heat Shock Protein 27 by Derivative of Artemisinin, Artesunate.

Myeloperoxidase (MPO) Is a Key Regulator of Oxidative Stress-Mediated Apoptosis in Myeloid Leukemic Cells.

A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.

Email alerts

ASH Publications

American Society of Hematology

Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: An Open-Label, Multicenter, Phase 2 Clinical Trial in China

Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism

A Novel Putative Mechanism of Anti-Myeloma Activity Targeted Against Heat Shock Protein 27 by Derivative of Artemisinin, Artesunate.

Myeloperoxidase (MPO) Is a Key Regulator of Oxidative Stress-Mediated Apoptosis in Myeloid Leukemic Cells.

A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only